​

GeneDx Ownership | Who Owns GeneDx?

OverviewForecastRevenueFinancialsChartTranscripts

GeneDx Ownership Summary

GeneDx is owned by 69.51% institutional investors, 20.28% insiders, and 10.21% retail investors. Gagnon securities is the largest institutional shareholder, holding 1.33% of WGS shares.

WGS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGeneDx69.51%20.28%10.21%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryHealthcare Information Services Stocks 54.42%10.35%35.24%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Gagnon securities359.38K1.33%$27.62M
Zweig-dimenna associates309.50K1.14%$23.79M
Assenagon asset management267.61K0.99%$20.57M
Gagnon advisors187.62K0.69%$14.42M
Allspring global investments90.15K0.33%$7.18M
Calamos advisors59.53K0.22%$4.58M
Legal advantage investments34.10K0.13%$2.62M
Legato capital management27.69K0.10%$2.13M
Baader bank aktiengesellschaft6.70K0.02%$514.96K
Sjs investment consulting3.57K0.01%$274.47K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Gagnon advisors187.62K9.23%$14.42M
Gagnon securities359.38K5.57%$27.62M
Zweig-dimenna associates309.50K1.78%$23.79M
Legal advantage investments34.10K1.39%$2.62M
Legato capital management27.69K0.28%$2.13M
Sjs investment consulting3.57K0.05%$274.47K
Evolution wealth advisors2.63K0.03%$202.30K
Baader bank aktiengesellschaft6.70K0.03%$514.96K
Assenagon asset management267.61K0.03%$20.57M
Calamos advisors59.53K0.02%$4.58M

Top Buyers

HolderShares% AssetsChange
Zweig-dimenna associates309.50K1.78%309.50K
Allspring global investments90.15K0.01%89.97K
Legato capital management27.69K0.28%12.96K
Pfg investments3.27K0.02%3.27K
Evolution wealth advisors2.63K0.03%2.63K

Top Sellers

HolderShares% AssetsChange
Gagnon securities359.38K5.57%-182.57K
Gagnon advisors187.62K9.23%-67.44K
Assenagon asset management267.61K0.03%-61.64K
Calamos advisors59.53K0.02%-25.48K
Precision wealth strategies---8.57K

New Positions

HolderShares% AssetsChangeValue
Zweig-dimenna associates309.50K1.78%309.50K$23.79M
Pfg investments3.27K0.02%3.27K$251.64K
Evolution wealth advisors2.63K0.03%2.63K$202.30K

Sold Out

HolderChange
Precision wealth strategies-8.57K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202414557.61%18,835,00115.66%691.86%9746.97%25127.27%
Jun 30, 20249250.82%16,284,87717.09%612.15%6688.57%1137.50%
Mar 31, 20246122.00%13,908,27011.80%532.33%3594.44%8-50.00%
Dec 31, 202350-13.79%12,440,649-10.79%471.64%18-21.74%16-5.88%
Sep 30, 202358-6.45%13,944,728-0.06%541.79%23-58.93%17750.00%

Recent Insider Transactions

DateNameRoleActivityValue
Jan 07, 2025Feeley Kevin CHIEF FINANCIAL OFFICERSell$330.37K
Jan 07, 2025Feeley Kevin CHIEF FINANCIAL OFFICERSell$86.87K
Jan 07, 2025Feeley Kevin CHIEF FINANCIAL OFFICERSell$2.25M
Jan 07, 2025Feeley Kevin CHIEF FINANCIAL OFFICERSell$667.31K
Jan 07, 2025Stueland Katherine Chief Executive OfficerSell$2.22M

Insider Transactions Trends

DateBuySell
2024 Q4-38
2024 Q3-26
2024 Q277
2024 Q129
2023 Q4311

WGS Ownership FAQ

Who Owns GeneDx?

GeneDx shareholders are primarily institutional investors at 69.51%, followed by 20.28% insiders and 10.21% retail investors. The average institutional ownership in GeneDx's industry, Healthcare Information Services Stocks , is 54.42%, which GeneDx exceeds.

Who owns the most shares of GeneDx?

GeneDx’s largest shareholders are Gagnon securities (359.38K shares, 1.33%), Zweig-dimenna associates (309.5K shares, 1.14%), and Assenagon asset management (267.61K shares, 0.99%). Together, they hold 3.46% of GeneDx’s total shares outstanding.

Does Blackrock own GeneDx?

BlackRock is not among the top 10 institutional shareholders of GeneDx.

Who is GeneDx’s biggest shareholder by percentage of total assets invested?

Gagnon advisors is GeneDx’s biggest shareholder by percentage of total assets invested, with 9.23% of its assets in 187.62K GeneDx shares, valued at 14.42M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools